p53 immunostaining pattern is a useful surrogate marker for TP53 gene mutations

Abstract Background TP53 is the most frequently mutated gene in the human cancer, and the awareness of its mutational status is useful in the diagnosis and treatment of cancer patients. In the present study, we investigated the association between TP53 gene mutations and p53 immunohistochemical stai...

Full description

Bibliographic Details
Main Authors: You-Na Sung, Deokhoon Kim, Jihun Kim
Format: Article
Language:English
Published: BMC 2022-12-01
Series:Diagnostic Pathology
Subjects:
Online Access:https://doi.org/10.1186/s13000-022-01273-w
_version_ 1811188195137683456
author You-Na Sung
Deokhoon Kim
Jihun Kim
author_facet You-Na Sung
Deokhoon Kim
Jihun Kim
author_sort You-Na Sung
collection DOAJ
description Abstract Background TP53 is the most frequently mutated gene in the human cancer, and the awareness of its mutational status is useful in the diagnosis and treatment of cancer patients. In the present study, we investigated the association between TP53 gene mutations and p53 immunohistochemical staining (IHC) patterns and non-genetic effect of MDM2 as a negative regulator of p53. Methods A total of 135 solid cancer cases with next generation sequencing data were subjected to p53 IHC and classified as overexpression, null type or usual pattern. Results TP53 mutation was observed in 104 out of 135 cases (77.0%). When the TP53 mutations were annotated into DISRUPTED (truncations, frameshifts, splice site mutations, and deep deletions) and IF-DBD (in-frame mutations in the DNA binding domain), the null type p53 IHC pattern was associated with DISRUPTED mutations (sensitivity 86.2%, specificity 97.2%) while the overexpression pattern was associated with IF-DBD mutations (sensitivity 100%, specificity 81.7%). The specificity of p53 IHC usual pattern predicting wild type TP53 was also as high as 100%. Regardless of MDM2 amplification, p53 IHC pattern showed a perfect association with TP53 mutation pattern. Conclusions p53 IHC pattern (overexpression, null type, usual) reasonably predicted TP53 mutational status (DISRUPTED, IF-DBD), and MDM2 amplification status did not have any impact on the p53 IHC pattern.
first_indexed 2024-04-11T14:16:26Z
format Article
id doaj.art-1e8c11b3f8fe4c979a970e3fdfda667d
institution Directory Open Access Journal
issn 1746-1596
language English
last_indexed 2024-04-11T14:16:26Z
publishDate 2022-12-01
publisher BMC
record_format Article
series Diagnostic Pathology
spelling doaj.art-1e8c11b3f8fe4c979a970e3fdfda667d2022-12-22T04:19:23ZengBMCDiagnostic Pathology1746-15962022-12-011711910.1186/s13000-022-01273-wp53 immunostaining pattern is a useful surrogate marker for TP53 gene mutationsYou-Na Sung0Deokhoon Kim1Jihun Kim2Department of Pathology, Asan Medical Center, University of Ulsan College of MedicineDepartment of Pathology, Asan Medical Center, University of Ulsan College of MedicineDepartment of Pathology, Asan Medical Center, University of Ulsan College of MedicineAbstract Background TP53 is the most frequently mutated gene in the human cancer, and the awareness of its mutational status is useful in the diagnosis and treatment of cancer patients. In the present study, we investigated the association between TP53 gene mutations and p53 immunohistochemical staining (IHC) patterns and non-genetic effect of MDM2 as a negative regulator of p53. Methods A total of 135 solid cancer cases with next generation sequencing data were subjected to p53 IHC and classified as overexpression, null type or usual pattern. Results TP53 mutation was observed in 104 out of 135 cases (77.0%). When the TP53 mutations were annotated into DISRUPTED (truncations, frameshifts, splice site mutations, and deep deletions) and IF-DBD (in-frame mutations in the DNA binding domain), the null type p53 IHC pattern was associated with DISRUPTED mutations (sensitivity 86.2%, specificity 97.2%) while the overexpression pattern was associated with IF-DBD mutations (sensitivity 100%, specificity 81.7%). The specificity of p53 IHC usual pattern predicting wild type TP53 was also as high as 100%. Regardless of MDM2 amplification, p53 IHC pattern showed a perfect association with TP53 mutation pattern. Conclusions p53 IHC pattern (overexpression, null type, usual) reasonably predicted TP53 mutational status (DISRUPTED, IF-DBD), and MDM2 amplification status did not have any impact on the p53 IHC pattern.https://doi.org/10.1186/s13000-022-01273-wTP53 geneImmunohistochemistryMutationp53 proteinAssociation
spellingShingle You-Na Sung
Deokhoon Kim
Jihun Kim
p53 immunostaining pattern is a useful surrogate marker for TP53 gene mutations
Diagnostic Pathology
TP53 gene
Immunohistochemistry
Mutation
p53 protein
Association
title p53 immunostaining pattern is a useful surrogate marker for TP53 gene mutations
title_full p53 immunostaining pattern is a useful surrogate marker for TP53 gene mutations
title_fullStr p53 immunostaining pattern is a useful surrogate marker for TP53 gene mutations
title_full_unstemmed p53 immunostaining pattern is a useful surrogate marker for TP53 gene mutations
title_short p53 immunostaining pattern is a useful surrogate marker for TP53 gene mutations
title_sort p53 immunostaining pattern is a useful surrogate marker for tp53 gene mutations
topic TP53 gene
Immunohistochemistry
Mutation
p53 protein
Association
url https://doi.org/10.1186/s13000-022-01273-w
work_keys_str_mv AT younasung p53immunostainingpatternisausefulsurrogatemarkerfortp53genemutations
AT deokhoonkim p53immunostainingpatternisausefulsurrogatemarkerfortp53genemutations
AT jihunkim p53immunostainingpatternisausefulsurrogatemarkerfortp53genemutations